News | Leadsynbio completes RMB 450 million Pre-IPO financing to accelerate new product industrialization and market expansion

Recently, Leadsynbio completed a RMB 450 million Pre-IPO financing round.

[ Details ]Sep 30,2026

News | Leadsynbio's fermentation-produced NMN achieves Self-GRAS status, securing compliant access to the U.S. market

Recently, Leadsynbio’s microbial-fermentation-produced NMN has officially passed the authentication of U.S. Self-GRAS. This signifies that our NMN can be sold and used as a safe and compliant food ingredient in the U.S. market, providing crucial supportfor Leadsynbio’s global expansion.

[ Details ]Sep 03,2026

Market | Leadsynbio showcased at the World Natural Health Ingredients Expo 2026

From August 24 to 26, 2026, Leadsynbio made a strong presence at the 6th World Natural & Health Ingredients Expo (WPE&WHPE 2026), engaging in in-depth exchanges with industry partners and clientson topics ranging from natural health ingredients to broader collaboration opportunities.

[ Details ]Aug 28,2026

NMN & Hair health: Resent research review

Stress, hormonal shifts, and late nights are taking a toll on hair health, especially among the young. Androgenetic alopecia only adds to the challenge. Yet amid the search for solutions, NMN has evolved from a mere clue into an evidence-backed answer.

[ Details ]Aug 12,2026

News | Leadsynbio was featured on Suzhou News, showcasing our biomanufacturing lab

Leadsynbio was recently featured on Suzhou News. The segment will take you inside our biomanufacturing lab, offering a firsthand look at our development and deployment of synthetic biology.

[ Details ]Aug 11,2026

News | Leadsynbio took part in State Science and Technology Award‑winning project

Recently, theproject in which Leadsynbio participated was awarded the Second Prize of the 2025 State Scientific and Technological Progress Award.

[ Details ]Jul 14,2026

Market | Anhui Liberty Showcased at China Veterinary Drug Conference and Exhibition 2026

On June 18–19, China Veterinary Drug Conference and Exhibition 2026 was held at the Hefei Binhu International Convention and Exhibition Center. Anhui Liberty Pharmaceutical Co., Ltd., a wholly‑owned subsidiary of Leadsynbio, joined the provincial delegationas a representative of outstanding animal health enterprises from Anhui, engaging with industry peers to explore new dynamics in the sector.

[ Details ]Jun 22,2026

Leadsynbio has been honored with second prize of the Provincial Science and Technology Progress Award

Recently, Leadsynbio has been honored withsecond prize of the Hunan Provincial Science and Technology Progress Award. The award-winning project’s achievements were selected as a landmark product in the 2026 Hunan Provincial Future IndustryInnovation and Development Excellent Typical Cases, gaining dual provincial authoritative recognition.

[ Details ]Jun 01,2026

Market | Leadsynbio shines at CPHI China 2026 with a diversified biomanufacturing product portfolio

From June 16 to 18, Leadsynbio made a strong impression atCPHI China 2026, showcasing a range of synthetic biology achievements and its internationally competitive product portfolio, while engaging with industry peers to explore future trends and partnership opportunities.

[ Details ]Jun 18,2026

Leadsynbio has been recognized as a "Key Nurturing Enterprise in Biomanufacturing" in Suzhou

On May 14th, Lesdsynbio was invited to attend the Suzhou Biomanufacturing Industry Development Conference and was awarded the title of "Key Nurturing Enterprise in Biomanufacturing" in Suzhou.

[ Details ]May 19,2026